TROP2 Antibodies Drug Conjugate ADC Clinical Trials Market Opportunity 2028

MLA

“TROP2 Antibodies Drug Conjugate ADC Clinical Trials Market Opportunity 2028.” GlobeNewswire, 22 Feb. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.738133300&authtype=sso&custid=ns315887.

APA

TROP2 Antibodies Drug Conjugate ADC Clinical Trials Market Opportunity 2028. (2023, February 22). GlobeNewswire.

Chicago

GlobeNewswire. 2023. “TROP2 Antibodies Drug Conjugate ADC Clinical Trials Market Opportunity 2028,” February 22. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.738133300&authtype=sso&custid=ns315887.